Skip to main content
. 2019 May 7;27(5):601–611. doi: 10.3727/096504018X15399945637736

Figure 8.

Figure 8

Effect of baicalein on tumor growth of CNE1- or CNE2-transplanted tumor. After the nasopharyngeal carcinoma xenograft model was established with CNE1 or CNE2 cells, mice were treated with 40 μM DDP (positive control) or different dosages of baicalein. On the fifth day, the tumor tissue was collected and weighed. (a) Tumor size of CNE1-transplanted tumor; (b) tumor weight of CNE1-transplanted tumor; (c) relative tumor volume of CNE1-transplanted tumor; (d) tumor size of CNE2-transplanted tumor; (e) tumor weight of CNE2-transplanted tumor; (f) relative tumor volume of CNE2-transplanted tumor; (g) tumor inhibition rates (TIR) and T/C of CNE1-transplanted tumor; (h) TIR and T/C of CNE2-transplanted tumor. *p < 0.05 compared to control.